Status:
WITHDRAWN
Cardiovascular Magnetic Resonance Guided Open Artery Trial for Revascularization of Late Presenting ST Elevation Myocardial Infarction
Lead Sponsor:
Sheffield Teaching Hospitals NHS Foundation Trust
Conditions:
STEMI
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Patients with STEMI are usually treated with primary PCI in contemporary practice. However, primary PCI is currently deemed unbeneficial or potentially harmful in patients presenting late after a STEM...
Detailed Description
Stable patients with late presenting STEMI will be prospectively recruited into this study from 5 large primary PCI centres in the UK. Ethical approval from a Research Ethics Committee and written inf...
Eligibility Criteria
Inclusion
- STEMI patients presenting \>12 hours, and within 28 days, after symptom onsent.
- Stable patients with no on-going features of ischaemia (chest pain, dynamic ECG changes)
Exclusion
- Inability to give informed consent
- Standard CMR contra-indications
- Haemodynamic instability (requiring on-going intravenous therapy or respiratory support)
- Previous coronary artery bypass grafting and cardiomyopathy
- Estimated glomerular filtration rate \<30ml/min/1.73m2
- End-stage malignancy or expected life expectancy of less than 12 months.
Key Trial Info
Start Date :
June 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2023
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT05374265
Start Date
June 1 2022
End Date
June 1 2023
Last Update
May 16 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sheffield Teaching Hospitals NHS FT
Sheffield, England, United Kingdom, S10 2JF